Sana Biotechnology Inc. Common Stock (SANA)
Stock · NASDAQ · Health Care
$3.93as of 8/28/2026
Price chart
Open in TradingViewActive signals
About SANA
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product,…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 142
- Website
- sana.com/
Fundamentals
- 1-day range
- $3.89$4.12
- Market cap
- $884.97M
- P/E (trailing)
- —
- P/E (forward)
- -7.08
- EPS (trailing)
- $-0.94
- Dividend yield
- —
- Beta
- 2.20
- Avg. volume
- 3.12M
Forecasts
7 analyst ratings
Sana Biotechnology Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SANASana Biotechnology Inc. Common Stock$3.93▼ 3.91%Market cap $884.97MP/E —$2.61$6.55
- SLDBSolid Biosciences Inc. Common Stock$9.78▼ 3.46%Market cap $789.57MP/E —$3.79$11.45
- MGTXMeiraGTx Holdings plc Ordinary Shares$13.8▼ 2.40%Market cap $1.10BP/E 15.54$6.62$15.35
- AGMBAgomAb Therapeutics NV American Depositary Shares$13.17▼ 4.84%Market cap $665.83MP/E —$8.75$17.82
- ALLOAllogene Therapeutics Inc. Common Stock$2.01▼ 3.83%Market cap $635.08MP/E —$1.04$4.46
- VORVor Biopharma Inc. Common Stock$22.66▼ 3.70%Market cap $1.16BP/E —$6.5$49.95
- IMTXImmatics N.V. Ordinary Shares$9.45▲ 0.91%Market cap $1.21BP/E —$5.05$12.41
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SANA Sana Biotechnology Inc. Common Stock | $884.97M | — | $3.93 | ▼ 3.91% | $2.61$6.55 |
| SLDB Solid Biosciences Inc. Common Stock | $789.57M | — | $9.78 | ▼ 3.46% | $3.79$11.45 |
| MGTX MeiraGTx Holdings plc Ordinary Shares | $1.10B | 15.54 | $13.8 | ▼ 2.40% | $6.62$15.35 |
| AGMB AgomAb Therapeutics NV American Depositary Shares | $665.83M | — | $13.17 | ▼ 4.84% | $8.75$17.82 |
| ALLO Allogene Therapeutics Inc. Common Stock | $635.08M | — | $2.01 | ▼ 3.83% | $1.04$4.46 |
| VOR Vor Biopharma Inc. Common Stock | $1.16B | — | $22.66 | ▼ 3.70% | $6.5$49.95 |
| IMTX Immatics N.V. Ordinary Shares | $1.21B | — | $9.45 | ▲ 0.91% | $5.05$12.41 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- B of A Securities Maintains Buy on Sana Biotechnology, Lowers Price Target to $6benzinga · 8/14/2026
- B of A Securities Maintains Buy on Sana Biotechnology, Lowers Price Target to $6Benzinga · 8/14/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 8/10/2026
- Sana Biotechnology Q2 Adj. EPS $(0.13) Beats $(0.15) EstimateBenzinga · 8/10/2026
Insider Activity
Insider Actions →- Hans Edgar Bishop · July 6, 2026 · Grant6.3K
- Michelle Seitz · June 4, 2026 · Grant90.0K
- Alise Reicin · June 4, 2026 · Grant90.0K
- Rosiello Robert L. · June 4, 2026 · Grant90.0K
- Bilenker Joshua H. · June 4, 2026 · Grant90.0K
- Hans Edgar Bishop · June 4, 2026 · Grant90.0K
- Richard Mulligan · June 4, 2026 · Grant90.0K
- Yang Patrick Y · June 4, 2026 · Grant90.0K
- Robert Nelsen · June 4, 2026 · Grant90.0K
- Hans Edgar Bishop · April 6, 2026 · Grant7.8K
- Steve Harr · March 9, 2026 · Tax Withholding12.8K @ $3.1
- Steve Harr · March 9, 2026 · Tax Withholding11.5K @ $3.13
- Susan D. Wyrick · March 9, 2026 · Tax Withholding1.0K @ $3.1
- Susan D. Wyrick · March 9, 2026 · Tax Withholding3.3K @ $3.13
- Steve Harr · March 7, 2026 · Option Exercise50.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 160.75M
- Total value held
- $460.98M
- Institutional holders
- 193
- Unknown37.43M
- Unknown25.00M
- Unknown14.24M
- Unknown10.54M
- Unknown10.22M
- Unknown7.43M
- Unknown6.61M
- Unknown4.18M
- Unknown4.00M
- Unknown3.20M
See the full, filterable feed with live charts on the MarketWall dashboard.